Loading...

Sunshine Biopharma, Inc.

SBFMWNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.23
$0.01(4.59%)

Sunshine Biopharma, Inc. (SBFMW) Company Profile & Overview

Explore Sunshine Biopharma, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Sunshine Biopharma, Inc. (SBFMW) Company Profile & Overview

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOSteve N. Slilaty

Contact Information

332 216 1147
6500 Trans-Canada Highway, Pointe-Claire, QC, H9R 0A5

Company Facts

52 Employees
IPO DateFeb 15, 2022
CountryCA
Actively Trading

Frequently Asked Questions

;